共 64 条
Long-term endoscopic surveillance of patients with Barrett's esophagus.: Incidence of dysplasia and adenocarcinoma:: A prospective study
被引:188
作者:
Conio, M
Blanchi, S
Lapertosa, G
Ferraris, R
Sablich, R
Marchi, S
D'Onofrio, V
Lacchin, T
Iaquinto, G
Missale, G
Ravelli, P
Cestari, R
Benedetti, G
Macrì, G
Fiocca, R
Munizzi, F
Filiberti, R
机构:
[1] Natl Inst Canc Res, Dept Gastroenterol, I-16145 Genoa, Italy
[2] Natl Inst Canc Res, Dept Environm Epidemiol, I-16145 Genoa, Italy
[3] Univ Genoa, Dept Pathol, Genoa, Italy
[4] Osped Mauriziano Umberto 1, Dept Gastroenterol, Turin, Italy
[5] Osped Civile, Dept Gastroenterol, Pordenone, Italy
[6] Univ Pisa, Dept Gastroenterol, Pisa, Italy
[7] Osped Moscati, Dept Gastroenterol, Avellino, Italy
[8] Univ Brescia, Div Endoscopy, Brescia, Italy
[9] Osped Civile, Dept Gastroenterol, Seriate, Italy
[10] Univ Florence, Dept Gastroenterol, Florence, Italy
关键词:
HIGH-GRADE DYSPLASIA;
ESOPHAGOGASTRIC JUNCTION;
INTESTINAL METAPLASIA;
GASTRIC-CARCINOMA;
RISING INCIDENCE;
CANCER-RISK;
FOLLOW-UP;
PREVALENCE;
DIAGNOSIS;
ASSOCIATION;
D O I:
10.1016/S0002-9270(03)00629-4
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
OBJECTIVE: Barrett's esophagus (BE) is a premalignant condition for which regular endoscopic follow-up is usually advised. We evaluated the incidence of esophageal adenocarcinoma (AC) in patients with BE and the impact of endoscopic surveillance on mortality from AC. METHODS: A cohort of newly diagnosed BE patients was studied prospectively. Endoscopic and histological surveillance was recommended every 2 yr. Follow-up status was determined from hospital and registry office records and telephone calls to the patients. RESULTS: From 1987 to 1997, BE was diagnosed in 177 patients. We excluded three with high-grade dysplasia (HGD) at the time of enrollment. Follow-up was complete in 166 patients (135 male, 31 female). The mean length of endoscopic follow-up was 5.5 yr (range 0.5-13.3). Lowgrade dysplasia (LGD) was present initially in 16 patients (9.6%) and found during follow-up in another 24 patients. However, in 75% of cases, LGD was not confirmed on later biopsies. HGD was found during surveillance in three patients (1.8%), one with simultaneous AC; two with HGD developed AC later. AC was detected in five male patients during surveillance. The incidence of AC was 1/220 (5/ 1100) patient-years of total follow-up, or 1/183.6 (5/918) patient-years in subjects undergoing endoscopy. Four AC patients died, and one was alive with advanced-stage tumor. The mean number of endoscopies performed for surveillance, rather than for symptoms, was 2.4 (range 1-10) per patient. During the follow-up years the cohort had a total of 528 examinations and more than 4000 biopsies. CONCLUSIONS: The incidence of AC in BE is low, confirming recent data from the literature reporting an overestimation of cancer risk in these patients. In our patient cohort, surveillance involved a large expenditure of effort but did not prevent any cancer deaths. The benefit of surveillance remains uncertain. (C) 2003 by Am. Coll. of Gastroenterology.
引用
收藏
页码:1931 / 1939
页数:9
相关论文